COVID-19 Vaccination Approvals: A Legal and Bioethical Framework

Date: 02/24/22
Time: 2:00-3:30 PM ET

Difficulty: Intermediate

Overview: This webinar will focus on the FDA vaccine approval process, how the practice of medicine permits offlabel uses for FDA-approved products, the challenges operating within the confines of an Emergency Use Authorization (EUA), and other life sciences aspects of using pharmaceuticals to quell the COVID-19 pandemic. Panelists will also address bioethical considerations regarding vaccines, vaccine mandates, and vaccine trials, including how EUAs may undermine clinical research and data collection.

Speaker Information:

  • Brian Malkin, Partner, McDermott Will & Emery LLP
  • Holly Fernandez Lynch, John Russell Dickson, MD Presidential Assistant Professor of Medical Ethics, University of Pennsylvania


Continuing Education:

AHLA’s live distance learning webinars are pre-approved for CLE credit in the following states: AL, IL, KS, ME, NE, OH, PA, RI, SC, TN, TX, VA and WV. Please refer to the Distance Learning CLE State Chart on our Continuing Education page to review the reporting procedure in these states.

CPE: AHLA is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be addressed to the National Registry of CPE Sponsors, 150 Fourth Avenue North, Nashville, TN 37219-2417. Website: www.nasba.org. For further information, please visit our Continuing Education Page.

AHLA is seeking CPE credits for live and on demand webinars. The maximum number of credits available is 1.50.